Read More Scince News General info Health 7 days ago Cutting TV Time Could Slash Midlife Depression Risk 43% A large Lifelines cohort study finds that replacing TV-watching with physical activity or sleep lowers the risk of major depression—effects are strongest in middle-aged adults, with up to a 43% risk reduction.
Read More Scince News Health 7 days ago MIT Method Reboots Retina to Restore Vision in Amblyopia MIT researchers found that temporarily silencing the retina can 'reboot' visual circuits and restore responsiveness in mice with amblyopia, suggesting a potential new path for treating lazy eye beyond childhood.
Read More Scince News Health 7 days ago Small Muscle Temperature Rises Boost Speed and Power New research shows raising muscle temperature by about 1°C can improve speed and power by ~3.5%. Active, sport-specific warm-ups combine heat and neural priming to boost explosive performance.
Read More Scince News Health 7 days ago Harnessing Astrocytes: Sox9 Clears Alzheimer’s Plaques Baylor researchers show that boosting the transcription factor Sox9 reprograms astrocytes to clear amyloid plaques in mice, preserving memory. This finding points to a new glia-targeted approach for Alzheimer’s therapies.
Read More Scince News Health 8 days ago Simple Compound Reverses Alzheimer's Signs in Rats A simple, low-cost compound called L10 rescued memory and reduced neuroinflammation in a rat model of Alzheimer's by removing excess copper from beta-amyloid plaques, offering a promising path toward clinical trials.
Read More Scince News Health 8 days ago Midlife and Later Exercise Cuts Dementia Risk by Up to 45% Analysis of Framingham Heart Study data shows high physical activity in midlife and later life cuts dementia risk by up to 45%, and late-life exercise benefits people with APOE ε4 genetic risk.
Read More Scince News Health 9 days ago Ultra-Processed Foods: A Global Public Health Emergency Landmark Lancet papers warn that ultra-processed foods are displacing traditional diets worldwide, increasing chronic disease risk. Experts call for coordinated policies — warning labels, taxes, subsidy shifts and limits on marketing.
Read More Scince News Health 9 days ago Could a Skin Cream Deliver Insulin and End Needles? A pH-responsive polymer enables insulin to cross the skin barrier in lab and animal tests. Topical OP-I delivered sustained glucose control in mice and minipigs, pointing to a future without injections.
Read More Scince News Health 10 days ago Root Canal Treatment May Lower Blood Sugar and Risk A study of 65 patients suggests treating chronic root canal infections can reduce systemic inflammation and improve blood glucose and metabolic markers over two years, linking oral health with diabetes and heart disease risk.
Read More Scince News Health 10 days ago Immune 'Assassins' Target Senescent Cells to Slow Aging Scientists have discovered CD4-Eomes immune cells that target senescent 'zombie' cells, reducing inflammation and tissue scarring in mice. This finding reshapes thinking about immune roles in aging and future therapies.
Read More Scince News Health 10 days ago Why Winter Dinner Timing Really Matters for Your Health Shorter winter days can shift circadian rhythms and metabolism. Chrononutrition research shows earlier, consistent dinners can improve blood sugar, sleep and mood. Practical tips for timing meals and adjusting to individual needs.
Read More Scince News Health 10 days ago Common Gut Microbiome Patterns in Neurodivergent Kids A Slovakian study of 117 children finds overlapping gut microbiome changes in autism, ADHD and anorexia nervosa. Shared shifts in bacterial groups hint at diet, inflammation and a gut–brain feedback loop.
Read More Scince News Health 11 days ago Stress-Sensitive Neurons That Drive Brain Blood Flow A rare class of type-I nNOS neurons appears to regulate global brain blood flow, vasomotion, and slow-wave activity in mice. Loss of these stress-sensitive cells may link sleep disruption to impaired waste clearance and neurodegeneration.
Read More Scince News Health 11 days ago Metformin and Exceptional Longevity: New Evidence for Women A long-term observational study finds women with type 2 diabetes who began metformin had a ~30% lower risk of dying before age 90 compared with sulfonylurea users, highlighting metformin's potential geroprotective effects and the need for randomized trials.
Read More Scince News Health 11 days ago Metformin and Exceptional Longevity: New Evidence for Women A long-term observational study finds women with type 2 diabetes who began metformin had a ~30% lower risk of dying before age 90 compared with sulfonylurea users, highlighting metformin's potential geroprotective effects and the need for randomized trials.
Read More Scince News Health 11 days ago Can High-Dose Vitamin B3 Ease Long COVID Brain Fog? A randomized clinical trial tested high dose nicotinamide riboside, a vitamin B3 form, to raise NAD plus and explore effects on brain fog, fatigue and sleep in people with long COVID. Results hint at benefit for some symptoms.
Read More Scince News Health 11 days ago Cutting Arsenic in Water Slashed Deaths by Half, Study A 20-year study in Bangladesh finds that reducing arsenic in drinking water can cut deaths from cancer, heart disease and chronic illness by up to 50% — even for people long exposed. Evidence supports urgent testing and remediation.
Read More Scince News Health 11 days ago How Alcohol Hijacks Sugar Metabolism to Fuel Addiction A University of Colorado study finds alcohol stimulates internal fructose production via the enzyme KHK, linking sugar metabolism to increased drinking and liver damage. Blocking KHK lowered alcohol intake and liver injury in mice.
Read More Scince News Health 12 days ago Teen Conflict with Fathers May Accelerate Biological Aging A 17-year University of Virginia study links adolescent conflict — especially fights with fathers and aggressive peer behavior — to accelerated biological aging and higher health risk by age 30.
Read More Scince News Health 12 days ago New Molecule SU212 Shows Promise Against TNBC Growth OHSU researchers report SU212, a molecule that degrades enolase 1 (ENO1), suppresses triple-negative breast cancer growth in humanized mice. The finding opens a path toward clinical trials and broader anti-cancer uses.
